吸入・点鼻スプレージェネリック薬の市場規模、シェア、動向分析レポート：薬物クラス別、適応症別、患者層別、エンドユーザー別、流通チャネル別、地域別、セグメント別予測、2022年～2030年

吸入・点鼻スプレージェネリック薬市場の成長と動向

グランドビューリサーチ社の最新レポートによると、世界の吸入・点鼻スプレージェネリック薬市場規模は2030年までに384億米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR8.96%で拡大すると予測されています。新製品の発売、慢性呼吸器疾患の蔓延、費用対効果の高い医薬品に対する需要の高まり、老年人口の増加などが、市場成長を後押しする主な要因となっています。

費用対効果の高い医薬品に対する需要の高まりと、ジェネリック医薬品の使用に対する政府の支援は、予測期間中に吸入・鼻腔スプレー用ジェネリック医薬品の需要を促進すると予想されます。例えば、日本政府は医薬品支出全体を規制するために、安価なジェネリック医薬品の使用を促進しています。これは、過去10年間におけるジェネリック医薬品の使用を奨励する規制の施行によって達成されました。

Teva Pharmaceuticals、Glenmark Specialty S.A.、Hikma Pharmaceuticals PLCなどの大手メーカー間でM&A、パートナーシップ、コラボレーションが増加していることも、成長を推進する大きな要因の1つとなっています。例えば、2022年1月、Glenmark Pharmaceuticals Ltd.のスイス子会社であるGlenmark Specialty S.A.は、Lotus International Pte.Ltd.と提携し、ベトナム、香港、シンガポールでリラトリス点鼻薬を販売することになりました。本契約により、グレンマークスペシャリティ S.A.はリヤルトリスの製造・供給を行い、Lotus International Pte.Ltd.が商業化します。同様に、2020年2月、グレンマーク・スペシャルティは、米国におけるリャルトリシンの商業化について、ヒグマ・ファーマシューティカルズPLCとライセンス契約を締結しました。

製薬会社による呼吸器系薬剤の探索や吸入・点鼻薬の後発品承認における広範な研究は、成長を促進すると予測されます。例えば、2021年3月、シプラ・インクは、片頭痛治療に適応するイミトレックス点鼻薬の後発品であるスマトリプタン点鼻薬のANDA承認を米国FDAから取得しました。また、2020年5月には、「ミグラナル」の後発品である「ジヒドロエルゴタミンメシル酸塩点鼻液」のANDA承認とともに、FDAから競合後発品指定を受けました。

吸入・点鼻スプレージェネリック薬市場レポートハイライト

薬物クラス別では、COPDと喘息の高い有病率に起因する気管支拡張薬が2021年の市場を独占している

慢性閉塞性肺疾患（COPD）適応症のセグメントは、ジェネリック製品の発売や中低所得国におけるCOPDの有病率の増加により、予測期間中に最も速い成長を遂げると予想される

患者層別では、公害、喫煙、花粉などの環境アレルゲンへの曝露の増加により、小児患者が予測期間中に最も速い成長を遂げると予想される

慢性疾患の有病率の上昇と慢性呼吸器疾患に苦しむ高齢者人口の増加により、2021年には在宅ケアエンドユーザーセグメントが市場を席巻

オンライン薬局の販売チャネルは、低い処方箋費用、インターネット普及率の増加、アクセスの容易さといった消費者ニーズにより、予測期間中に最も速い成長を見せると予想される

2021年には、北米が市場を独占しました。これは、同地域におけるジェネリック医薬品の開発および上市に向けた主要企業の戦略的イニシアティブと協力関係によるものです。

目次

第1章 調査手法と範囲

• 市場セグメンテーション
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
  • 一次情報一覧
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ1：コモディティフローアプローチ
    • アプローチ2：ボトムアップアプローチを使用した国別の市場推定
• 世界市場：CAGR計算
• 調査の仮定
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場概要

第3章 市場変数、動向、範囲

• 市場系列の見通し
  • 親会社の市場見通し
• 規制の枠組み
• 浸透と成長の見通しのマッピング
• パイプライン分析
• 市場力学
  • 市場促進要因分析
  • 市場抑制分析
• PESTEL分析

第4章 世界の吸入・点鼻スプレージェネリック薬市場- セグメント分析、医薬品クラス別、2018年-2030年（100万米ドル）

• 世界の吸入および点鼻スプレーのジェネリック医薬品市場：医薬品クラスの変動分析
• 気管支拡張薬
• 配合剤
• コルチコステロイド
• うっ血除去スプレー
• 抗ヒスタミン薬
• その他

第5章 世界の吸入および点鼻スプレーのジェネリック医薬品市場-セグメント分析、適応症別、2018年～2030年（100万米ドル）

• 世界の吸入および点鼻スプレーのジェネリック医薬品市場：適応症の変動分析
• 喘息
• 慢性閉塞性肺疾患（COPD）
• アレルギー性鼻炎
• その他

第6章 世界の吸入および鼻スプレージェネリック医薬品市場-セグメント分析、患者人口統計、2018年から2030年（100万米ドル）

• 世界の吸入および点鼻スプレーのジェネリック医薬品市場：患者人口統計の変動分析
• 成人患者
• 小児患者
• 高齢患者

第7章 世界の吸入・点鼻スプレージェネリック薬市場-セグメント分析、エンドユーザー別、2018年から2030年（100万米ドル）

• 世界の吸入および点鼻スプレーのジェネリック医薬品市場：エンドユーザーの変動分析
• 病院
• がん研究所
• その他

第8章 世界の吸入・点鼻スプレージェネリック薬市場-セグメント分析、流通チャネル別、2018年～2030年（100万米ドル）

• 世界な吸入および点鼻スプレーのジェネリック医薬品市場：流通チャネルの動きの分析
• 小売薬局
• 病院薬局
• オンライン薬局

第9章 吸入・点鼻スプレージェネリック薬市場：セグメント分析、地域別、2018年から2030年（100万米ドル）

• 吸入および点鼻スプレーのジェネリック医薬品市場：地域の変動分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • ロシア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第10章 世界の吸入・点鼻スプレージェネリック薬市場：競合分析

• 主要な市場参加者別最近の動向と影響分析
  • 主要な取引と戦略的提携の分析
    • 新製品の発売
    • 合併と買収
    • パートナーシップと契約
• 会社の分類
  • イノベーター
  • 市場のリーダー
  • 新興プレーヤー
  • ヒートマップ分析
• 会社の市況分析
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 潜在的なエンドユーザーのリスト
  • 主要企業の市場シェア分析、2021年
• Company Market Share, 2021
  • 競合ダッシュボード分析
• プライベートカンパニー
  • 主要新興企業一覧
  • 地域ネットワークマップ
• 企業プロファイル
  • Teva Pharmaceuticals
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Viatris Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Akorn, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Cipla Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Sandoz（Novartis AG）
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Apotex Inc.
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Hikma Pharmaceuticals PLC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
  • Sun Pharma
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Beximco Pharmaceuticals Limited
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Nephron Pharma
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 Global Inhalation & Nasal Spray Generic Drugs Market, By Region, 2018 - 2030 (USD Million)
• Table 4 Global Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 5 Global Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 6 Global Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 7 Global Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 8 Global Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 9 North America Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 10 North America Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 11 North America Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 12 North America Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 13 North America Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 14 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 15 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 16 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 17 U.S. Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 18 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 19 Canada Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 20 Canada Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 21 Canada Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 22 Canada Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 23 Canada Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 24 Europe Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 25 Europe Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 26 Europe Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 27 Europe Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 28 Europe Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 29 Germany Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 30 Germany Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 31 Germany Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 32 Germany Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 33 Germany Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 34 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 35 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 36 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 37 U.K. Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 38 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 39 France Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 40 France Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 41 France Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 42 France Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 43 France Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 44 Italy Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 45 Italy Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 46 Italy Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 47 Italy Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 48 Italy Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 49 Spain Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 50 Spain Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 51 Spain Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 52 Spain Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 53 Spain Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 54 Russia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 55 Russia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 56 Russia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 57 Russia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 58 Russia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 64 Japan Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 65 Japan Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 66 Japan Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 67 Japan Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 68 Japan Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 69 China Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 70 China Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 71 China Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 72 China Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 73 China Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 74 India Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 75 India Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 76 India Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 77 India Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 78 India Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 79 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 80 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 81 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 82 South Korea Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 83 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 84 Australia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 85 Australia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 86 Australia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 87 Australia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 88 Australia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 89 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 90 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 91 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 92 Singapore Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 93 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 94 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 95 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 96 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 97 Latin America Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 98 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 99 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 100 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 101 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 102 Brazil Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 103 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 104 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 105 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 106 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 107 Mexico Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 108 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 109 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 110 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 111 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 112 Argentina Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 113 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 114 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 115 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 116 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 117 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 118 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 119 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 120 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 121 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 122 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 123 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 124 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 125 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 126 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 127 South Africa Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 128 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
• Table 129 UAE Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
• Table 130 UAE Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
• Table 131 UAE Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
• Table 132 UAE Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
• Table 133 UAE Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Inhalation &nasal spray generic drugs market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Inhalation &nasal spray generic drugs market snapshot
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook, revenue, 2021 (USD Million)
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Inhalation &nasal spray generic drugs market driver impact
• Fig. 14 Inhalation & nasal spray generic drugs market restraint impact
• Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 16 Industry Analysis - Porter's
• Fig. 17 Strategy mapping
• Fig. 18 Inhalation &nasal spray generic drugs market: Drug class outlook and key takeaways
• Fig. 19 Inhalation &nasal spray generic drugs market: Drug class movement analysis & market share 2021 & 2030
• Fig. 20 Bronchodilators market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Combination market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Decongestant sprays market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Inhalation &nasal spray generic drugs market: Indication outlook and key takeaways
• Fig. 27 Inhalation &nasal spray generic drugs market: Indication movement analysis & market share 2021 & 2030
• Fig. 28 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Allergic rhinitis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Inhalation & nasal spray generic drugs market: Patient demographics outlook and key takeaways
• Fig. 33 Inhalation & nasal spray generic drugs market: Patient demographics movement analysis & market share 2021 & 2030
• Fig. 34 Adult patient market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Pediatric patient market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Geriatric patient market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Inhalation & nasal spray generic drugs market: End-user outlook and key takeaways
• Fig. 38 Inhalation & nasal spray generic drugs market: End-user movement analysis & market share 2021 & 2030
• Fig. 39 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Inhalation & nasal spray generic drugs market: Distribution channel outlook and key takeaways
• Fig. 43 Inhalation & nasal spray generic drugs market: Distribution channel movement analysis & market share 2021 & 2030
• Fig. 44 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Hospitals pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Inhalation & nasal spray generic drugs: Regional outlook and key takeaways
• Fig. 48 Regional outlook, 2021 & 2030
• Fig. 49 North America
• Fig. 50 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 U.S.
• Fig. 52 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Canada
• Fig. 54 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Europe
• Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 U.K.
• Fig. 58 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Germany
• Fig. 60 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 France
• Fig. 62 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Italy
• Fig. 64 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Spain
• Fig. 66 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Russia
• Fig. 68 Russia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Asia Pacific
• Fig. 70 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Japan
• Fig. 72 Japan market estimates and forecast, 2018 - 2030(USD Million)
• Fig. 73 China
• Fig. 74 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 India
• Fig. 76 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 South Korea
• Fig. 78 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 Australia
• Fig. 80 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 Singapore
• Fig. 82 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Latin America
• Fig. 84 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 Brazil
• Fig. 86 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Mexico
• Fig. 88 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 Argentina
• Fig. 90 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Middle East & Africa
• Fig. 92 MEA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 South Africa
• Fig. 94 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 95 Saudi Arabia
• Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 97 UAE
• Fig. 98 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 99 Market differentiators
• Fig. 100 Key company market share analysis, 2021
• Fig. 101 Company market position analysis
• Fig. 102 Competitive dashboard analysis
• Fig. 103 Regional network map

Inhalation And Nasal Spray Generic Drugs Market Growth & Trends:

The global inhalation and nasal spray generic drugs market size is expected to reach USD 38.40 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.96% from 2022 to 2030. New product launches, mounting prevalence of chronic respiratory diseases, growing demand for cost-effective medicines, and rising geriatric population are some of the major factors boosting the market growth.

Rising demand for cost-effective medicines and government support for the use of generics is expected to drive the demand for inhalation and nasal spray generic drugs over the forecast period. For instance, the Government of Japan has been promoting the usage of inexpensive generic drugs in order to regulate the overall pharmaceutical expenditure. This was accomplished through the execution of regulations to encourage the use of generic drugs in the past decade.

Rising number of M&A, partnerships, and collaborations among leading manufacturers including Teva Pharmaceuticals, Glenmark Specialty S.A., and Hikma Pharmaceuticals PLC is another major factor propelling the growth. For instance, in January 2022, Glenmark Specialty S.A., a Swiss subsidiary of Glenmark Pharmaceuticals Ltd., partnered with Lotus International Pte. Ltd. for marketing Ryaltris nasal spray in Vietnam, Hong Kong, and Singapore. Under this agreement, Glenmark Specialty S.A. will manufacture and supply Ryaltris, and Lotus International Pte. Ltd. will commercialize the product. Similarly, in February 2020, Glenmark Specialty signed a licensing agreement with Hikma Pharmaceuticals PLC to commercialize Ryaltrisin in the U.S.

Extensive research in the respiratory drug discovery and generic product approvals of inhalation and nasal drugs by pharmaceutical companies are projected to fuel growth. For instance, in March 2021, Cipla Inc. received ANDA approval from the U.S. FDA for Sumatriptan Nasal Spray, a generic equivalent of Imitrex Nasal Spray indicated for migraine treatment. In addition, in May 2020, the company received Competitive Generic Therapy designation from FDA along with ANDA approval for Dihydroergotamine Mesylate Nasal Spray, a generic version of Migranal.

Inhalation And Nasal Spray Generic Drugs Market Report Highlights:

• By drug class, bronchodilators dominated the market in 2021 owing to the high prevalence of COPD and asthma in the population

• The chronic obstructive pulmonary disease (COPD) indication segment is expected to witness the fastest growth over the forecast period due to the launch of generic products and increased prevalence of COPD in low- and middle-income countries

• Based on patient demographics, the pediatric patients segment is expected to witness the fastest growth over the forecast period due to an increase in pollution, smoking, and exposure to environmental allergens such as pollens

• The homecare end-user segment dominated the market in 2021 owing to a rise in the prevalence of chronic diseases and rising geriatric population suffering from chronic respiratory diseases

• The online pharmacies distribution channel segment is expected to witness the fastest growth over the forecast period due to consumer needs for low prescription costs, increased internet penetration, and ease of access

• North America dominated the market in 2021 due to strategic initiatives and collaborations among key players for the development and launch of generic products in this region

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market segmentation
  • 1.1.1 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database
  • 1.3.2 GVR'S internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
  • 1.3.6 List of primary sources
• 1.4 Information or data analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity flow analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Abbreviations
• 1.11 Objectives
  • 1.11.1 Objective 1
  • 1.11.2 Objective 2
  • 1.11.3 Objective 3
  • 1.11.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market outlook
• 3.2 Regulatory framework
• 3.3 Penetration and Growth Prospect Mapping
• 3.4 Pipeline Analysis
• 3.5 Market Dynamics
  • 3.5.1 Market driver analysis
  • 3.5.2 Market restraint analysis
• 3.6 PESTEL Analysis

Chapter 4 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Drug Class, 2018 - 2030 (USD Million)

• 4.1 Global Inhalation & Nasal Spray Generic Drugs Market: Drug Class Movement Analysis
• 4.2 Bronchodilators
  • 4.2.1 Bronchodilators market estimates and forecast, 2018 - 2030 (USD Million)
• 4.3 Combination Drugs
  • 4.3.1 Combination drugs market estimates and forecast, 2018 - 2030 (USD Million)
• 4.4 Corticosteroids
  • 4.4.1 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
• 4.5 Decongestant Sprays
  • 4.5.1 Decongestant sprays market estimates and forecast, 2018 - 2030 (USD Million)
• 4.6 Antihistamines
  • 4.6.1 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
• 4.7 Others
  • 4.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, by Indication, 2018 - 2030 (USD Million)

• 5.1 Global Inhalation & Nasal Spray Generic Drugs Market: Indication Movement Analysis
• 5.2 Asthma
  • 5.2.1 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
• 5.3 Chronic Obstructive Pulmonary Disease (COPD)
  • 5.3.1 Chronic obstructive pulmonary disease market estimates and forecast, 2018 - 2030 (USD Million)
• 5.4 Allergic Rhinitis
  • 5.4.1 Allergic rhinitis market estimates and forecast, 2018 - 2030 (USD Million)
• 5.5 Others
• 5.5. 1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Patient Demographics, 2018 - 2030 (USD Million)

• 6.1 Global Inhalation & Nasal Spray Generic Drugs Market: Patient Demographics Movement Analysis
• 6.2 Adult Patient
  • 6.2.1 Adult patient market estimates and forecast, 2018 - 2030 (USD Million)
• 6.3 Pediatric Patient
  • 6.3.1 Pediatric patient market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4 Geriatric Patient
  • 6.4.1 Geriatric patient market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By End-User, 2018 - 2030 (USD Million)

• 7.1 Global Inhalation & Nasal Spray Generic Drugs Market: End-user Movement Analysis
• 7.2 Hospitals
  • 7.2.1 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
• 7.3 Cancer Institutes
  • 7.3.1 Cancer Institutes market estimates and forecast, 2018 - 2030 (USD Million)
• 7.4 Others
  • 7.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

• 8.1 Global Inhalation & Nasal Spray Generic Drugs Market: Distribution ChannelMovement Analysis
• 8.2 Retail Pharmacies
  • 8.2.1 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 8.3 Hospitals Pharmacies
  • 8.3.1 Hospitals pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 8.4 Online Pharmacies
  • 8.4.1 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Inhalation & Nasal Spray Generic Drugs Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 9.1 Inhalation & Nasal Spray Generic Drugs Market: Regional Movement Analysis
  • 9.1.1 North America
    • 9.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.1.2 U.S.
    • 9.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.1.3 Canada
    • 9.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.1.2 Europe
    • 9.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2.2 U.K.
    • 9.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2.3 Germany
    • 9.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2.4 France
    • 9.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2.5 Spain
    • 9.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2.6 Italy
    • 9.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2.7 Russia
    • 9.1.2.7.1 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.1.3 Asia Pacific
    • 9.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3.2 Japan
    • 9.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3.3 China
    • 9.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3.4 India
    • 9.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3.5 Australia
    • 9.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3.6 South Korea
    • 9.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3.7 Singapore
    • 9.1.3.7.1 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.1.4 Latin America
    • 9.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.4.2 Brazil
    • 9.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.4.3 Mexico
    • 9.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.4.4 Argentina
    • 9.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.1.5 Middle East & Africa
    • 9.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.5.2 South Africa
    • 9.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.5.3 Saudi Arabia
    • 9.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.5.4 United Arab Emirates
    • 9.1.5.4.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Global Inhalation & Nasal Spray Generic Drugs Market: Competitive Analysis

• 10.1 Recent Developments and Impact Analysis, by Key Market Participants
  • 10.1.1 Major deals & strategic alliances analysis
    • 10.1.1.1 New Product Launches
    • 10.1.1.2 Mergers and Acquisitions
    • 10.1.1.3 Partnerships & Agreements
• 10.2 Company Categorization
  • 10.2.1 Innovators
  • 10.2.2 Market Leaders
  • 10.2.3 Emerging Players
  • 10.2.4 Heat Map Analysis
• 10.3 Company Market Position Analysis
• 10.4 Vendor Landscape
  • 10.4.1 List of Key Distributors and Channel Partners
  • 10.4.2 List of Potential End Users
  • 10.4.3 Key Company Market Share Analysis, 2021
• 10.5 Company Market Share, 2021
  • 10.5.1 Competitive Dashboard Analysis
• 10.6 Private Companies
  • 10.6.1 List of Key Emerging Companies
  • 10.6.2 Regional Network Map
• 10.7 Company Profiles
  • 10.7.1 Teva Pharmaceuticals
    • 10.7.1.1 Company overview
    • 10.7.1.2 Financial performance
    • 10.7.1.3 Product benchmarking
    • 10.7.1.4 Strategic initiatives
  • 10.7.2 Viatris Inc.
    • 10.7.2.1 Company overview
    • 10.7.2.2 Financial performance
    • 10.7.2.3 Product benchmarking
    • 10.7.2.4 Strategic initiatives
  • 10.7.3 Akorn, Inc.
    • 10.7.3.1 Company overview
    • 10.7.3.2 Financial performance
    • 10.7.3.3 Product benchmarking
    • 10.7.3.4 Strategic initiatives
  • 10.7.4 Cipla Inc.
    • 10.7.4.1 Company overview
    • 10.7.4.2 Financial performance
    • 10.7.4.3 Product benchmarking
    • 10.7.4.4 Strategic initiatives
  • 10.7.5 Sandoz (Novartis AG)
    • 10.7.5.1 Company overview
    • 10.7.5.2 Financial performance
    • 10.7.5.3 Product benchmarking
    • 10.7.5.4 Strategic initiatives
  • 10.7.6 Apotex Inc.
    • 10.7.6.1 Company overview
    • 10.7.6.2 Product benchmarking
    • 10.7.6.3 Strategic initiatives
  • 10.7.7 Hikma Pharmaceuticals PLC
    • 10.7.7.1 Company overview
    • 10.7.7.2 Financial performance
    • 10.7.7.3 Product benchmarking
  • 10.7.8 Sun Pharma
    • 10.7.10.1 Company overview
    • 10.7.10.2 Financial performance
    • 10.7.10.3 Product benchmarking
    • 10.7.10.4 Strategic initiatives
  • 10.7.9 Beximco Pharmaceuticals Limited
    • 10.7.9.1 Company overview
    • 10.7.9.2 Financial performance
    • 10.7.9.3 Product benchmarking
    • 10.7.9.4 Strategic initiatives
  • 10.7.10 Nephron Pharma
    • 10.7.10.1 Company overview
    • 10.7.10.2 Financial performance
    • 10.7.10.3 Product benchmarking
    • 10.7.10.4 Strategic initiatives